[1]
Andrew, F.; Lynda, W. Pantoprazole: A review of its pharmacological properties and therapeutic use in acid related disorders. Drugs, 1996, 51(3), 460-482.
[2]
Paul, W.J. Pantoprazole: A New proton pump indibitor. Clin. Therapeut., 2000, 22(11), 1268-1293.
[3]
Distrutti, E.; Fiorucci, S.; Hauer, S.K.; Pensi, M.O.; Vanaisa, M.; Morelli, A. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment. Pharmacol. Ther., 2002, 16, 613-622.
[4]
Mucci, A.; Nolfe, G.; Maj, M. Levosulpiride: A review of its clinical use in psychiatry. Pharmacol. Res., 1995, 31(2), 95-101.
[5]
Rossi, F.; Forgione, A. Pharmaco toxicological aspects of levosulpiride. Pharmacol. Res., 1995, 31(2), 81-94.
[6]
Guslandi, M. The clinical use of levosulpiride. Curr. Ther. Res., 1993, 53(5), 484-501.
[7]
Sony, M.; Ashley, R.; Chenlu, T.; Qiang, C. An update on the use pf pantoprazole as a treatment for gastro esophageal reflux disease. Clin. Exp. Gastro., 2010, 3, 11-16.
[8]
Balasekhara, R.C.; Sai, H.S.B.; Bahlul, Z.A.; Babu, R.C.; Chandrasekhar, K.B.; Mukkanti, K. Development and validation of a sensitive bioanalytical method for the quantitative estimation of pantoprazole in human plasma samples by LC-MS/MS: Application to bioequivalence study. J. Chromatogr. B., 2010, 878, 1499-1505.
[9]
Yun, L.; Mei-Juan, D.; Jing, M.; Shu, W.; Xiao-Li, W.; Hui-Juan, X. Quantification of pantoprazole in human plasma using LC-MS/MS for pharmacokinetics and bioequivalence study. Eur. J. Drug Metab. Pharmacokinet., 2011, 35, 147-155.
[10]
Ling, J.; Wang, H.; Shentu, J.Z.H. Determination of pantoprazole in human plasma by HPLC-MS. Chi J. Mod. App. Pharm, 2005, 54(6), 306-308.
[11]
Osmair, P.; Celso, H.O.; Rafael, E.B-A.; Vinicius, M.R.; Gustavo, D.M.; de Nucci, G. Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard. Arzneim. For. Sch. Drug Res., 2004, 54(6), 314-319.
[12]
Ramakrishna, N.V.S.; Vishwottam, K.M.; Wishu, S.; Koteshwara, M. High-performance liquid chromatography method for the quantification of pantoprazole in human plasma. J. Chromatogr. B., 2005, 822, 326-329.
[13]
Safwan, A.; Soulafa, O. A modified high-performance liquid chromatographic method for the analysis of pantoprazole sodium in pharmaceutical dosage forms using lansoprazole as internal standard. Arabian. J. Chem., 2016, 9, 114-119.
[14]
Kothapalli, L.P.; Inamdar, A.A.; Nanda, R.K.; Thomas, A.B. Development and validation of a stability indicating RP-HPLC method for the simultaneous estimation of pantoprazole sodium sesquihydrate and levosulpiride in a combined dosage form. Int. J. Res. Pharm. Sci, 2014, 4(4), 32-38.
[15]
Nicolas, P.; Fauvelle, F.; Ennachachibi, A. Improved determination of sulpiride in plasma by ion pair liquid chromatography with fluorescence detection. J. Chromatogr., 1986, 381, 393-400.
[16]
Bok, P.; Ya, M.; Hye, Y.J.; Hui-Kyun, K.; Hye, W.L.; Yong-Bok, L. Hydrophillic interaction liquid chromatography-tandem mass spectrometry for the determination of levosulpiride in human plasma. J. Chromatogr. B., 2004, 809, 345-350.
[17]
Jin-Hee, P.; Yoo-Sin, P.; Si-Youn, R.; Hyun-Jin, K.; Ok-Hwa, J.; Yun-Sik, L. Rapid quantification of levosulpiride in human plasma using RP-HPLC-MS/MS for pharmacokinetic and bioequivalence study. Biomed. Chromatogr., 2009, 23, 1350-1356.
[18]
Prasad, B.P.; Hae, W.L.; Mi-Sun, L.; Sook, J.S.; Eun-Hee, K.; Jeonghyeon, P. Liquid chromatography-tandem mass spectrometry quantification of levosulpiride in human plasma and its application to bioequivalence study. J. Chromatogr. B., 2010, 878, 2280-2285.
[19]
Chunduri, R.H.B.; Dannana, G.S. Development and validation of a high throughput UPLC-MS/MS method for simultaneous quantification of esomeprazole, rabeprazole and levosulpiride in human plasma. J. Pharm. Anal., 2016, 6, 190-198.
[20]
Rakesh, D.; Pal, T.K. Method development & validation of LCMS/MS for atorvastatin and olmesartan in human plasma to trace drug interaction of formulation. Curr. Pharmaceut. Anal., 2015, 11(1), 43-52.
[21]
Draft guidance for industry: Bioanalytical method validation. US
Department of Health and Human Services, Food and Drug Administration
Centre for Drug Evaluation and Research and Centre
for Veterinary Medicine, September 2013..
[23]
EMEA guideline on Bioanalytical Method Validation, 2011..